Published in J Cell Mol Med on November 27, 2006
Issues affecting molecular staging in the management of patients with melanoma. J Cell Mol Med (2007) 0.92
Melanoma. N Engl J Med (2006) 8.80
Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev (2006) 4.24
In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol (1987) 1.90
Epidemiology of melanoma. Clin Exp Dermatol (2000) 1.17
Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med (2011) 45.46
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med (2011) 26.90
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet (2008) 3.62
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev (2006) 2.87
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol (2011) 2.62
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J Clin Oncol (2002) 2.57
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol (2009) 2.48
Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. J Clin Oncol (2012) 2.42
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial. Lancet Oncol (2012) 2.03
The role of BRAF V600 mutation in melanoma. J Transl Med (2012) 2.00
Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases. Crit Rev Oncol Hematol (2007) 1.75
Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood (2010) 1.74
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. J Clin Oncol (2013) 1.67
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort. J Transl Med (2014) 1.59
The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). J Nucl Med (2006) 1.53
Clinical genetic testing for familial melanoma in Italy: a cooperative study. J Am Acad Dermatol (2009) 1.45
Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer (2011) 1.28
Vitamin D and skin cancer: a meta-analysis. Eur J Cancer (2008) 1.22
Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol Immunother (2003) 1.20
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy. Cancer Immunol Immunother (2011) 1.19
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program. Cancer Invest (2014) 1.06
Primary and recurrent retroperitoneal soft tissue sarcoma: prognostic factors affecting survival. J Surg Oncol (2006) 1.03
Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion. Cancer (2008) 1.03
Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991. J Clin Oncol (2010) 1.00
Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma. Clin Cancer Res (2007) 0.99
Anti-CTLA-4 antibody adjuvant therapy in melanoma. Semin Oncol (2010) 0.97
Desmoid tumors of the anterior abdominal wall: results from a monocentric surgical experience and review of the literature. Ann Surg Oncol (2009) 0.96
Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells. Proc Natl Acad Sci U S A (2014) 0.95
Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma. J Clin Oncol (2010) 0.93
Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations. World J Surg Oncol (2012) 0.93
Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. J Clin Oncol (2013) 0.92
Sentinel node biopsy in thin and thick melanoma. Ann Surg Oncol (2013) 0.92
Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991). Cancer Chemother Pharmacol (2009) 0.92
Treatment of metastatic melanoma with electrochemotherapy. J Surg Oncol (2014) 0.91
The cost of unresectable stage III or stage IV melanoma in Italy. J Exp Clin Cancer Res (2012) 0.91
Dermatoscopy of an invasive melanoma on the upper lip shows possible association with Laugier-Hunziker syndrome. J Am Acad Dermatol (2008) 0.90
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme. J Exp Clin Cancer Res (2014) 0.89
Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned? J Autoimmun (2008) 0.89
Oral lichen planus: a retrospective study of 633 patients from Bucharest, Romania. Med Oral Patol Oral Cir Bucal (2013) 0.88
Primary oral tuberculosis: a case series from Bucharest, Romania. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 0.87
Heat shock proteins and their use as anticancer vaccines. Clin Cancer Res (2004) 0.87
Pediatric melanoma: analysis of an international registry. Cancer (2013) 0.86
Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directions. J Surg Oncol (2011) 0.86
Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings. Recent Pat Anticancer Drug Discov (2008) 0.85
MicroRNA expression profiles in Kaposi's sarcoma. Pathol Oncol Res (2013) 0.85
Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents. Expert Opin Biol Ther (2014) 0.85
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme. J Exp Clin Cancer Res (2013) 0.84
Computer-aided diagnosis of melanocytic lesions. Anticancer Res (2005) 0.83
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging (2015) 0.83
Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma. Dermatology (2013) 0.83
Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread? Clin Exp Metastasis (2012) 0.82
Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients? Eur Radiol (2013) 0.82
Surgical management of suspicious melanocytic lesions in Italy. Dermatology (2013) 0.82
The evaluation of interstitial Cajal cells distribution in non-tumoral colon disorders. Rom J Morphol Embryol (2008) 0.80
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study). Eur J Cancer (2009) 0.80
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. J Transl Med (2014) 0.80
Characterization of oral keratinocyte stem cells and prospects of its differentiation to oral epithelial equivalents. Rom J Morphol Embryol (2010) 0.79
Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity. Anticancer Res (2007) 0.79
Subcutaneous immunoglobulins: product characteristics and their role in primary immunodeficiency disease. Int Rev Immunol (2012) 0.79
Modification of lymphoscintigraphic sentinel node identification before and after excisional biopsy of primary cutaneous melanoma. Melanoma Res (2008) 0.79
The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease. Expert Opin Biol Ther (2011) 0.78
HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future. Expert Rev Vaccines (2009) 0.78
Acantholytic squamous cell carcinoma: pathological study of nine cases with review of literature. Rom J Morphol Embryol (2014) 0.78
What is new in melanoma research? Vaccines, Basic and Translational Research in 2003: report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003. Melanoma Res (2004) 0.77
Oncophage: step to the future for vaccine therapy in melanoma. Expert Opin Biol Ther (2008) 0.77
Sunny holidays before and after melanoma diagnosis are respectively associated with lower Breslow thickness and lower relapse rates in Italy. PLoS One (2013) 0.77
Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk. Ann Surg Oncol (2005) 0.77
Autologous hematopoietic stem cell transplantation for systemic sclerosis. Curr Stem Cell Res Ther (2011) 0.77
Early diagnosis of malignant melanoma: Proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative Group. Int J Oncol (2003) 0.76
Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study. Melanoma Res (2015) 0.76
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations. Melanoma Res (2008) 0.75
Apoptosis in seborrheic keratoses: an open door to a new dermoscopic score. J Cell Mol Med (2012) 0.75
What is new in melanoma research: genetics and epidemiology of melanoma in 2003? Review of a workshop held in Milan in May 2003. Melanoma Res (2004) 0.75
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study). Cancer Immunol Immunother (2013) 0.75
Melanoma - what is new in sentinel node biopsy and locoregional treatments in 2003? Report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003. Melanoma Res (2004) 0.75
Impact of mole mapping in the Italian health system. Dermatology (2013) 0.75
Update: current management issues in malignant melanoma. Melanoma Res (2005) 0.75
Dermatoscopic and histopathological diagnosis of primary and metastatic melanoma: report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003. Melanoma Res (2004) 0.75
Management of small and intermediate congenital nevi: a nationwide survey in Italy. Dermatology (2013) 0.75
[The method of the sentinel lymph node]. Chir Ital (2002) 0.75
Keratoacanthoma centrifugum marginatum: an unusual clinical and histopathological diagnostic pitfall. Rom J Morphol Embryol (2017) 0.75
Combined approach for the biomechanical characterization of skin lesions. Conf Proc IEEE Eng Med Biol Soc (2015) 0.75
Basal cell carcinoma miming cutaneous melanoma. Rom J Morphol Embryol (2011) 0.75
Pelvic sentinel lymph node biopsy in melanoma patients: is it worthwhile? Melanoma Res (2010) 0.75
Diagnostic services for melanoma in Italy. Dermatology (2013) 0.75
Unknown Primary Melanoma: Worldwide Survey on Clinical Management. Dermatology (2017) 0.75
Ipilimumab targeting CD28-CTLA-4 axis: new hope in the treatment of melanoma. Curr Top Med Chem (2012) 0.75
Melanoma Task Force (META) Project in Italy: methodology. Dermatology (2013) 0.75
Trichilemmal carcinoma - a rare cutaneous malignancy: report of two cases. Rom J Morphol Embryol (2014) 0.75